Publikationen von Maik Ködel
Alle Typen
Zeitschriftenartikel (11)
2024
Zeitschriftenartikel
DNA methylation patterns of FKBP5 regulatory regions in brain and blood of humanized mice and humans. MOLECULAR PSYCHIATRY (2024)
2023
Zeitschriftenartikel
6 (1), 1031 (2023)
Stress-induced brain responses are associated with BMI in women. COMMUNICATIONS BIOLOGY
Zeitschriftenartikel
145 (4), S. 439 - 459 (2023)
Associations of psychiatric disease and ageing with FKBP5 expression converge on superficial layer neurons of the neocortex. ACTA NEUROPATHOLOGICA
Zeitschriftenartikel
120 (49), e2305773120 (2023)
High- throughput screening of glucocorticoid- induced enhancer activity reveals mechanisms of stress- related psychiatric disorders. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Zeitschriftenartikel
Extensive evaluation of DNA methylation of functional elements in the murine Fkbp5 locus using high-accuracy DNA methylation measurement via targeted bisulfite sequencing. EUROPEAN JOURNAL OF NEUROSCIENCE (2023)
2022
Zeitschriftenartikel
23 (19), 11448 (2022)
Genome-Wide Copy Number Variant and High-Throughput Transcriptomics Analyses of Placental Tissues Underscore Persisting Child Susceptibility in At-Risk Pregnancies Cleared in Standard Genetic Testing. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Zeitschriftenartikel
179 (5), S. 375 - 387 (2022)
Cell-Type-Specific Impact of Glucocorticoid Receptor Activation on the Developing Brain: A Cerebral Organoid Study. AMERICAN JOURNAL OF PSYCHIATRY 2020
Zeitschriftenartikel
117 (38), S. 23280 - 23285 (2020)
Glucocorticoid exposure during hippocampal neurogenesis primes future stress response by inducing changes in DNA methylation. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2019
Zeitschriftenartikel
11, 83 (2019)
Identification of dynamic glucocorticoid-induced methylation changes at the FKBP5 locus. CLINICAL EPIGENETICS
Zeitschriftenartikel
116 (23), S. 11370 - 11379 (2019)
Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-kappa B-driven inflammation and cardiovascular risk. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2018
Zeitschriftenartikel
11, 39 (2018)
HAM-TBS: high-accuracy methylation measurements via targeted bisulfite sequencing. EPIGENETICS & CHROMATIN Konferenzbeitrag (4)
2018
Konferenzbeitrag
83 (9, Suppl.), 192, S. S77 - S77 (2018)
Investigation of Prenatal Stress in the Cerebral Organoid Model: A Focus on Cell-Type Specific Responses Following Glucocorticoid Exposure. 73rd Annual Scientific Convention and Meeting, Annual
Meeting of the Society of Biological Psychiatry (SOBP), New York, NY, 10. Mai 2018 - 12. Mai 2018. Biological Psychiatry 2017
Konferenzbeitrag
42, W158, S. S576 - S576 (2017)
Investigation of Prenatal Stress in the Cerebral Organoid Model: A Focus on Cell-Type Specific Responses Following Glucocorticoid Exposure. 56th Annual Meeting of the American College of Neuropsychopharmacology
(ACNP), Palm Springs, CA, 03. Dezember 2017 - 07. Dezember 2017. NEUROPSYCHOPHARMACOLOGY
Konferenzbeitrag
124 (10), S. 1292 - 1292 (2017)
Aging- and stress-related epigenetic disinhibition of FKBP5 contributes to NF-κB-driven inflammation and cardiovascular risk. Conference of the World-Association-for-Stress-Related-and-Anxiety-Disorders (WASAD), Würzburg, Germany, 14. September 2017 - 16. September 2017. JOURNAL OF NEURAL TRANSMISSION
Konferenzbeitrag
42 (Suppl. 1), T26, S. S310 - S311 (2017)
Aging- and Stress-Related Epigenetic Disinhibition of FKBP5 Contributes to NF-KB-Driven Inflammation and Cardiovascular Risk. 56th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP), Palm Springs, CA, 03. Dezember 2017 - 07. Dezember 2017. NEUROPSYCHOPHARMACOLOGY Meeting Abstract (1)
2023
Meeting Abstract
75, S. S25 - S26. World Congress of Psychiatric Genetics (WCPG), Montreal, CANADA, 10. Oktober 2023 - 14. Oktober 2023. (2023)
CELL-TYPE SPECIFIC AGEING EFFECTS IN THE HUMAN ORBITOFRONTAL CORTEX AND IMPLICATIONS FOR PSYCHIATRIC DISEASE. In EUROPEAN NEUROPSYCHOPHARMACOLOGY,